Cyclic sulfones useful as mitochondrial sodium-calcium exchangers

Details for Australian Patent Application No. 2007293674 (hide)

Owner Novartis AG

Inventors Chiesi, Michele; Hintermann, Samuel

Agent Davies Collison Cave

Pub. Number AU-A-2007293674

PCT Pub. Number WO2008/028958

Priority 06120389.9 08.09.06 EP

Filing date 7 September 2007

Wipo publication date 13 March 2008

International Classifications

C07D 281/10 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/028958 Priority application(s): WO2008/028958

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293693-Diagnostic biomolecule(s)

2007293673-Vaccine